April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
The Existence of a Canonical Wnt Signaling Pathway in Gtm-3 Cells
Author Affiliations & Notes
  • W. Mao
    Cell Biol & Genetics, UNT Health Science Center, Fort Worth, Texas
  • R. J. Wordinger
    Cell Biol & Genetics, UNT Health Science Center, Fort Worth, Texas
  • A. F. Clark
    Cell Biol & Genetics, UNT Health Science Center, Fort Worth, Texas
  • Footnotes
    Commercial Relationships  W. Mao, None; R.J. Wordinger, None; A.F. Clark, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4884. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W. Mao, R. J. Wordinger, A. F. Clark; The Existence of a Canonical Wnt Signaling Pathway in Gtm-3 Cells. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4884.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Increased intraocular pressure (IOP) is the primary risk factor of glaucoma, and we have previously shown that the canonical Wnt signaling pathway plays a role in regulating IOP. In order to better understand Wnt signaling in the trabecular meshwork (TM), we investigated whether a similar canonical Wnt signaling pathway exists in GTM-3 cells, a transformed glaucomatous TM cell line widely used in glaucoma research.

Methods: : The Wnt signaling pathway in GTM-3 cells was examined using a TCF dual-luciferase reporter gene assay, and we determined the effects of Wnt signaling on the endogenous ß-catenin levels with Western immunoblots. For the dual luciferase assay, reporter vectors containing TCF cis-elements were transfected into GTM-3 cells, which were then treated with recombinant Wnt3a, Wnt5a with or without SFRP-1 at different concentrations. For Western blots, nuclear and cytoplasmic proteins were extracted from GTM-3 cells treated with or without Wnt3a and/or SFRP-1 for 4 hours. ß-catenin, Lamin A/C and GAPDH (nuclear and cytoplasmic protein loading controls, respectively) were probed with corresponding antibodies.

Results: : The dual-luciferase assay showed that Wnt3a dose-dependently induced luciferase expression in GTM-3 cells. The normalized relative luminescence unit (RLU) in GTM-3 cells increased 10 fold with 100ng/ml Wnt3a and 40 fold with 500ng/ml Wnt3a (both p<0.01). In contrast, Wnt5a only regulated luciferase expression with low efficacy. Treating GTM-3 cells with SFRP-1, an inhibitor of Wnt pathway, dose-dependently blocked the effect of Wnt3a with complete inhibition at 10ug/ml (p<0.01). Wnt3a caused the accumulation of endogenous ß-catenin in the nucleus and cytoplasm in GTM-3 cells, and this accumulation was also inhibited by SFRP-1.

Conclusions: : GTM-3 cells have a canonical Wnt signaling pathway. These cells will be useful in further examining Wnt/β-catenin signaling and identifying Wnt regulated genes in the TM.

Keywords: trabecular meshwork • gene/expression • outflow: trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×